13382285011
JAK Inhibitors

current location: Home > Medicine > Targeted Therapies > JAK Inhibitors

ALITOFATIB

Brief description:Tofacitinib is an oral small-molecule Janus kinase (JAK) inhibitor. JAKs are intracellular enzymes that transmit signals arising from cytokine or growth factor-receptor interactions on the cell membrane, influencing hematopoietic and immune cell function. Tofacitinib works by selectively inhibiting JAK1 and JAK3 kinase activity, blocking the JAK-STAT signaling pathway. This action inhibits the signal transduction of various pro-inflammatory cytokines (e.g., IL-6, IL-7, IL-15, IL-21), reduces the

basic information

Product model

vendor nature

private

Release time

2020-07-21

page views

Product details

Generic Name

Tofacitinib Citrate Tablets

Mechanism of Action

Tofacitinib is an oral small-molecule Janus kinase (JAK) inhibitor. JAKs are intracellular enzymes that transmit signals arising from cytokine or growth factor-receptor interactions on the cell membrane, influencing hematopoietic and immune cell function. Tofacitinib works by selectively inhibiting JAK1 and JAK3 kinase activity, blocking the JAK-STAT signaling pathway. This action inhibits the signal transduction of various pro-inflammatory cytokines (e.g., IL-6, IL-7, IL-15, IL-21), reduces the release of inflammatory mediators, and alleviates synovial inflammation and tissue damage in joints


Online message

Product Inquiry

  • Your name:

  • Common mailbox:

  • Your unit:

  • Contact number:

  • detailed address:

  • message content:

  • Company Name:

    Asian Frontier Pharmaceutical Information Co., Ltd.​

  • Hotline:

    +86 13382285011

  • Company address:

    No. 88, Moumou Industrial Zone, Tianhe District, Guangzhou City, Guangdong Province

  • E-mail address:

    504051920@qq.com

Code

Copyright © 2018-2026 Asian Frontier Pharmaceutical Information Co., Ltd.​ All rights reserved  sitemap.xml

Phone:13382285011